Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by VIKINGSTORMon Jan 15, 2012 7:41pm

298 Views

Post# 19406075

RE: A Vote

To Dart.

What would be the business advantage (exactly ! ) to Kane Biotech if Gord were replaced ??? How exactly would that change anything and speed up the process ?? I somehow doubt you have an credible answer to that but I'm willing to listen even if it serves only to be somewhat entertaining. Come on Dart or anyone else for that matter. Tell us why Gord should be replaced - exactly.

Bullboard Posts

Unique Battery Metals opportunity in Quebec